Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
30 Jul 2025
See more Chinese multinational Chery will open an R&D center in CataloniaChinese multinational Chery will open an R&D center in Catalonia
-
23 Jul 2025
See more Scopely in Catalonia: A Global Gaming Success StoryScopely in Catalonia: A Global Gaming Success Story
-
17 Jul 2025
See more Grifols invests €160 million in Barcelona and creates 400 jobs with a new plasma fractionation plantGrifols invests €160 million in Barcelona and creates 400 jobs with a new plasma fractionation plant
-
14 Jul 2025
See more Video game multinational Scopely opens its new tech hub in Barcelona, employing 700 peopleVideo game multinational Scopely opens its new tech hub in Barcelona, employing 700 people
